The abstract submission is officially open.
Abstract submission is an important part of the EHA-SWG Scientific Meeting on Shaping the Future of Mesenchymal Stromal Cells Therapy. As a participant you will have the opportunity to submit an abstract for this meeting, and (if accepted) have the possibility to discuss it with the international faculty and your peers.
A selection of abstracts will be eligible for acceptance during the meeting, the presentation format will be in the form of a poster and oral presentations. Presenting authors will receive an separate invitation.
You can submit a case on one of the following topics:
- Biology of MSCs
- Mechanisms of action
- Regulatory issues
- Clinical application
- Biomarkers and monitoring
The abstracts will be reviewed and allocated by the Scientific Program Committee. Submitting authors will be informed about the allocation before September 29, 2017.
Please note that the submission of an abstract constitutes a formal commitment by the author to attend the meeting (if the abstract is accepted) and if required present the abstract as a poster in the session and the time assigned by the Scientific Program Committee. We therefore recommend that submitters of abstracts register for the meeting simultaneously with abstract submission.
Should you have any questions, please contact firstname.lastname@example.org.